Posterior reversible encephalopathy syndrome (PRES) and myeloma

Posterior reversible encephalopathy syndrome (PRES) and myeloma

Posterior reversible encephalopathy syndrome (PRES) has rarely been described in myeloma, but chemotherapy is a known risk factor. We report 3 patients with myeloma who developed PRES, and analyzed them with 13 published cases, mostly women. The most frequent causative agents were proteasome inhibit...

Full description

Bibliographic Details
Main Authors: Ricardos Ghanem, Sylvie Glaisner, Arthur Bobin, Anne-Marie Ronchetti, Sophie Cereja, Bertrand Joly, Célia Salanoubat, Guillemette Fouquet
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Leukemia Research Reports
Subjects:
Myeloma
Neurotoxicity
Cerebrovascular complication
Posterior reversible encephalopathy syndrome
Chemotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S221304892300047X

Internet

http://www.sciencedirect.com/science/article/pii/S221304892300047X

Similar Items